查找临床试验

已按「慢阻肺」检索,对应国际通用词 COPD

试验不在中国怎么办?

共找到 87 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募不适用中国有中心NCT05775588

Long-term Effects of Endobronchial Valve Implantation on Cardiac Function and Skeletal Muscle Function

China

年龄 18 Years – 90 Years

China-Japan Friendship Hospital

正在招募不适用中国有中心NCT05799664

Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

China

年龄 40 Years – 85 Years

Hangzhou Broncus Medical Co., Ltd.

正在招募III 期中国有中心NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

United States、Argentina、Belgium、Brazil、Canada 等 12 国

年龄 40 Years – 80 Years

Sanofi

正在招募不适用中国有中心NCT07069829

Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

Argentina、Colombia、Egypt、Indonesia、Jordan 等 12 国

年龄 30 Years – 80 Years

AstraZeneca

正在招募不适用中国有中心NCT07236541

Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study

China

年龄 18 Years – 89 Years

Ming Zhong

正在招募不适用中国有中心NCT06756646

Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD

Taiwan

年龄 30 Years – 85 Years

National Cheng Kung University

正在招募不适用中国有中心NCT06168266

Effects of Eccentric Exercise Training in Patients With COPD

Taiwan

年龄 20 Years – 80 Years

Fu Jen Catholic University

正在招募不适用中国有中心NCT06772454

To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)

China

年龄 18 Years – 不限

Guangzhou Institute of Respiratory Disease

正在招募III 期中国有中心NCT06959095

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

United States、Argentina、Belgium、Canada、Chile 等 12 国

年龄 40 Years – 80 Years

GlaxoSmithKline

正在招募III 期中国有中心NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

United States、Brazil、Canada、Chile、China 等 12 国

年龄 40 Years – 80 Years

AstraZeneca

正在招募不适用中国有中心NCT06579872

Association Between Cardiopulmonary Function and Plantar Pressure in Patients With Chronic Obstructive Pulmonary Disease

Taiwan

年龄 45 Years – 65 Years

Fu Jen Catholic University

正在招募II 期中国有中心NCT07640451

A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

China

年龄 40 Years – 80 Years

Guangdong Hengrui Pharmaceutical Co., Ltd